Helix Acquisition Corp. III (HLXC) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Helix Acquisition Corp. III, a Cayman Islands-based special purpose acquisition company (SPAC), on August 14, 2026. The report addresses a regulatory deficiency notification received from The Nasdaq Stock Market regarding the company's continued listing status.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a listing compliance issue rather than financial performance.
Material Changes and Listing Status
- Deficiency Notice: On August 14, 2026, the Company received notice from Nasdaq that it failed to meet Listing Rule 5452(a)(2)(A), which requires a minimum of 300 total holders for continued listing on the Nasdaq Global Market.
- Current Trading Status: The notice is a notification of deficiency only. As of August 17, 2026, Class A ordinary shares (Symbol: HLXC) continue to trade on Nasdaq without interruption.
- Compliance Timeline: The Company has 45 calendar days to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
Outlook, Risks, and Management Commentary
Management intends to monitor the number of total holders and will consider implementing available options to regain compliance. The filing includes standard forward-looking statements warning that there is no assurance the Company will regain compliance within the applicable cure period. Risks include potential adverse effects on the business, stock price volatility, and the possibility of delisting if compliance is not achieved.
Investor Verification Checklist
- Verify the current number of total holders to assess the severity of the deficiency.
- Monitor the submission of the compliance plan within the 45-day window.
- Review the Company's Annual Report on Form 10-K for the year ended December 31, 2025, for detailed risk factors.
- Track any subsequent filings regarding the acceptance or rejection of the compliance plan by Nasdaq.